These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

460 related articles for article (PubMed ID: 23652165)

  • 101. Interim results: influenza A (H1N1) 2009 monovalent vaccination coverage --- United States, October-December 2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2010 Jan; 59(2):44-8. PubMed ID: 20094027
    [TBL] [Abstract][Full Text] [Related]  

  • 102. A study of the association between seasonal influenza vaccines and the increased risk of Guillain-Barré syndrome using Vaccine Adverse Event Reporting System, 2018-2019.
    Fujimori M; Hasegawa S; Sasaoka S; Iguchi K; Nakamura M
    Pharmazie; 2021 Sep; 76(9):437-443. PubMed ID: 34481535
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Guillain-Barré syndrome and influenza vaccines: A meta-analysis.
    Martín Arias LH; Sanz R; Sáinz M; Treceño C; Carvajal A
    Vaccine; 2015 Jul; 33(31):3773-8. PubMed ID: 25999283
    [TBL] [Abstract][Full Text] [Related]  

  • 104. [Vaccination against influenza and Guillain-Barre syndrome: are there any relations?].
    Wiercińska-Drapało A; Grzeszczuk A; Wasilewski K; Prokopowicz D
    Pol Merkur Lekarski; 2000 May; 8(47):360-1. PubMed ID: 10944963
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Guillain-Barré syndrome in children aged <15 years in Latin America and the Caribbean: baseline rates in the context of the influenza A (H1N1) pandemic.
    Landaverde JM; Danovaro-Holliday MC; Trumbo SP; Pacis-Tirso CL; Ruiz-Matus C
    J Infect Dis; 2010 Mar; 201(5):746-50. PubMed ID: 20102270
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Prediction of post-vaccination Guillain-Barré syndrome using data from a passive surveillance system.
    Luo C; Jiang Y; Du J; Tong J; Huang J; Lo Re V; Ellenberg SS; Poland GA; Tao C; Chen Y
    Pharmacoepidemiol Drug Saf; 2021 May; 30(5):602-609. PubMed ID: 33533072
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Relationship between occurrence of Guillain-Barre syndrome and mass campaign of measles and rubella immunization in Iranian 5-14 years old children.
    Esteghamati A; Gouya MM; Keshtkar AA; Mahoney F
    Vaccine; 2008 Sep; 26(39):5058-61. PubMed ID: 18662736
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Risk of Guillain-Barré syndrome after measles-mumps-rubella vaccination.
    Patja A; Paunio M; Kinnunen E; Junttila O; Hovi T; Peltola H
    J Pediatr; 2001 Feb; 138(2):250-4. PubMed ID: 11174624
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Effectiveness of 2008-09 trivalent influenza vaccine against 2009 pandemic influenza A (H1N1) - United States, May-June 2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Nov; 58(44):1241-5. PubMed ID: 19910912
    [TBL] [Abstract][Full Text] [Related]  

  • 110. The reporting sensitivity of the Vaccine Adverse Event Reporting System (VAERS) for anaphylaxis and for Guillain-Barré syndrome.
    Miller ER; McNeil MM; Moro PL; Duffy J; Su JR
    Vaccine; 2020 Nov; 38(47):7458-7463. PubMed ID: 33039207
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Guillain-Barré syndrome associated with H1N1 vaccination.
    Marin LF; Abrahão A; Carvalho FA; Santos WA; Dallalba CC; Barcelos LB; Silva GS; Oliveira AS
    Arq Neuropsiquiatr; 2010 Dec; 68(6):974-5. PubMed ID: 21243265
    [No Abstract]   [Full Text] [Related]  

  • 112. Association of Receipt of the Ad26.COV2.S COVID-19 Vaccine With Presumptive Guillain-Barré Syndrome, February-July 2021.
    Woo EJ; Mba-Jonas A; Dimova RB; Alimchandani M; Zinderman CE; Nair N
    JAMA; 2021 Oct; 326(16):1606-1613. PubMed ID: 34617967
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Population-Based Incidence of Guillain-Barré Syndrome During Mass Immunization With Viral Vaccines: A Pooled Analysis.
    Wang F; Wang D; Wang Y; Li C; Zheng Y; Guo Z; Liu P; Zhang Y; Wang W; Wang Y; Hou H
    Front Immunol; 2022; 13():782198. PubMed ID: 35185881
    [TBL] [Abstract][Full Text] [Related]  

  • 114. [Safety and effectiveness of the influenza vaccine: new data, new challenges].
    Trilla A
    Med Clin (Barc); 2013 Jul; 141(2):67-9. PubMed ID: 23768850
    [No Abstract]   [Full Text] [Related]  

  • 115. Neurologic adverse events following influenza A (H1N1) vaccinations in children.
    Lee SJ; Kim YO; Woo YJ; Kim MK; Nam TS; Cho YK
    Pediatr Int; 2012 Jun; 54(3):325-30. PubMed ID: 22299607
    [TBL] [Abstract][Full Text] [Related]  

  • 116. H1N1 and seasonal influenza vaccine safety in the vaccine safety datalink project.
    Lee GM; Greene SK; Weintraub ES; Baggs J; Kulldorff M; Fireman BH; Baxter R; Jacobsen SJ; Irving S; Daley MF; Yin R; Naleway A; Nordin JD; Li L; McCarthy N; Vellozzi C; Destefano F; Lieu TA;
    Am J Prev Med; 2011 Aug; 41(2):121-8. PubMed ID: 21767718
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Evaluating the safety of influenza vaccine using a claims-based health system.
    McCarthy NL; Gee J; Lin ND; Thyagarajan V; Pan Y; Su S; Turnbull B; Chan KA; Weintraub E
    Vaccine; 2013 Dec; 31(50):5975-82. PubMed ID: 24148577
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Guillain-Barré syndrome and influenza vaccines: current evidence.
    Sanz Fadrique R; Martín Arias L; Molina-Guarneros JA; Jimeno Bulnes N; García Ortega P
    Rev Esp Quimioter; 2019 Aug; 32(4):288-295. PubMed ID: 31232571
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Associations of Guillain-Barré syndrome with coronavirus disease 2019 vaccination: Disproportionality analysis using the World Health Organization pharmacovigilance database.
    Kim JE; Park J; Min YG; Hong YH; Song TJ
    J Peripher Nerv Syst; 2022 Sep; 27(3):206-214. PubMed ID: 35751472
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Risk of Guillain-Barré Syndrome Following COVID-19 Vaccines: A Nationwide Self-Controlled Case Series Study.
    Le Vu S; Bertrand M; Botton J; Jabagi MJ; Drouin J; Semenzato L; Weill A; Dray-Spira R; Zureik M
    Neurology; 2023 Nov; 101(21):e2094-e2102. PubMed ID: 37788935
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.